NOVEL PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE DOLASTATIN 10 DERIVATIVE

The present invention is directed to a pharmaceutical composition, comprisingat least one compound of formula (I), in combination with capecitabine, trastuzumab,pertuzumab, cisplatin or irinotecan for simultaneous, sequential or separateadministration in the treatment of cancer. La presente invencio...

Full description

Saved in:
Bibliographic Details
Main Authors MASANORI MIWA, FUMIE SAWAMURA, YUKO AOKI, HIROMI TANIMURA, TOSHIKAZU YAMAZAKI
Format Patent
LanguageEnglish
Spanish
Published 19.07.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to a pharmaceutical composition, comprisingat least one compound of formula (I), in combination with capecitabine, trastuzumab,pertuzumab, cisplatin or irinotecan for simultaneous, sequential or separateadministration in the treatment of cancer. La presente invencion esta dirigida a una composicion farmaceutica, que comprende al menos un compuesto de la formula (I), en combinacion con capecitabina, trastuzumab, pertuzumab, cisplatino o irinotecan para la administracion simultanea, secuencial o separada en el tratamiento de cancer.
Bibliography:Application Number: MX20070006430